摘要
RNA N-6-methyladenosine (m(6)A) modification is gradually thought to be an active participant in the considerable biological processes of glioblastoma (GB), providing us with a novel insight for exploring this disease. However, the role of RNA m(6)A modification duringthe epithelial mesenchymal transition (EMT) or vasculogenic mimicry (VM) progression has not been investigated in GB. Here we performed a research to validate the impact exerted by AlkB homolog 5 (ALKBH5), one of "erasers" for RNA m(6)A and methyltransferase-like 3 (METTL3) which adds m(6)A modification to the RNAs on the progression of EMT and VM in GB. In this study, we demonstrate that the m(6)A levels of RNAs were reduced in GB cells and glioma tissues. Patients with high mRNA expression of ALKBH5 acquired relatively shorter median overall survival (OS) time, while patients with relatively high expression of MEETL3 prolonged their disease free survival. ALKBH5 enhanced GB cell proliferation and influenced cell cycle in vitro. Decreased RNA m(6)A methylation enhanced the progression of the EMT and VM in glioblastoma cells. ALKBH5 strengthened glioblastoma growth and enhanced the EMT and VM process of glioblastoma in vivo. Our study uncovers that RNA m(6)A methylation suppresses the process of EMT and VM in glioblastoma, providing a new perspective to seek for a potential therapeutic target for GB.
学科与关键词
- ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in gliomaTang, Wenhui; Xu, Ningbo; Zhou, Jian; He, Zhenyan; Lenahan, Cameron; Wang, Chenyang; Ji, Huangyi; Liu, Boyang; Zou, Yujiao; Zeng, Huijun; Guo, Hongbo*Cell Death Discovery, 2022, 8(1): 497.被引 13
- Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell AnalysesYuan, Feng; Cai, Xiangming; Cong, Zixiang; Wang, Yingshuai; Geng, Yuanming; Aili, Yiliyaer; Du, Chaonan; Zhu, Junhao; Yang, Jin; Tang, Chao; Zhang, Aifeng; Zhao, Sheng; Ma, Chiyuan*Frontiers in Immunology, 2022, 13: 798583.被引 7
- Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomasCai, Zhiqiang; Zhang, Jianbo*; Liu, Ziying; Su, Jiahao; Xu, Jing; Li, Zhenjun; Meng, Hongliang; Zhang, Heng; Huang, Minjie; Zhao, Donghai; Duan, Chuanzhi; He, Xuying*Annals of Translational Medicine, 2021, 9(15): 1241.被引 10
